Literature DB >> 34976275

Beneficial Effects of Acupuncture as a Complementary Treatment for Patients Receiving Paroxetine For Major Depressive Disorder: A Meta-Analysis.

Minh Duc Nguyen1, Quoc Vinh Nguyen2, Cay Doan Ha3, Thanh Van Tran1, Linh Vu Phuong Dang4.   

Abstract

Objective: Major depressive disorder (MDD) is a major public health problem due to MDD's increasing incidence among adults worldwide. While selective serotonin reuptake inhibitors (SSRIs), such as paroxetine, are considered to be the most effective treatment for MDD, the adverse effects of SSRIs should not be neglected. The aim of this research was to evaluate the effectiveness of acupuncture as a complement to paroxetine systematically for improving quality of life (QoL) for patients with MDD. Methods and Materials: Chinese and English electronic databases were searched, randomized controlled clinical studies were collected, data entry was managed, and a meta-analysis was performed to evaluate the QoL of the patients pre and post treatment.
Results: There were 5 studies included in the review, in which the researchers compared the QoL of patients with MDD treated with: paroxetine + acupuncture (both electroacupuncture and traditional acupuncture) or paroxetine alone. In all aspects-including physical health, psychologic health, social relationships, and environment-patients treated with the combination therapy experienced a significant improvements in QoL compared the patients treated with the single therapy. Conclusions: Using acupuncture as a complementary treatment improved QoL in patients with MDD. Copyright 2021, Mary Ann Liebert, Inc., publishers.

Entities:  

Keywords:  acupuncture; major depressive disorder; meta-analysis; paroxetine; randomized controlled trial; systematic review

Year:  2021        PMID: 34976275      PMCID: PMC8716514          DOI: 10.1089/acu.2021.0038

Source DB:  PubMed          Journal:  Med Acupunct        ISSN: 1933-6586


  18 in total

1.  Quality of life in major depressive disorder before/after multiple steps of treatment and one-year follow-up.

Authors:  W W IsHak; J Mirocha; D James; G Tobia; J Vilhauer; H Fakhry; S Pi; E Hanson; R Nashawati; E D Peselow; R M Cohen
Journal:  Acta Psychiatr Scand       Date:  2014-06-23       Impact factor: 6.392

2.  Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder.

Authors:  D Bakish; P Cavazzoni; J Chudzik; A Ravindran; P D Hrdina
Journal:  Biol Psychiatry       Date:  1997-01-15       Impact factor: 13.382

Review 3.  Acupuncture and related techniques during perioperative period: A literature review.

Authors:  H Volkan Acar
Journal:  Complement Ther Med       Date:  2016-09-13       Impact factor: 2.446

4.  Major depressive disorder and impaired health-related quality of life among US older adults.

Authors:  Taeho Greg Rhee; David C Steffens
Journal:  Int J Geriatr Psychiatry       Date:  2020-07-19       Impact factor: 3.485

5.  Management of common adverse effects of antipsychotic medications.

Authors:  T Scott Stroup; Neil Gray
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

6.  Factors that influence the applicability of sham needle in acupuncture trials: two randomized, single-blind, crossover trials with acupuncture-experienced subjects.

Authors:  Hiroshi Tsukayama; Hitoshi Yamashita; Tomoaki Kimura; Kuniharu Otsuki
Journal:  Clin J Pain       Date:  2006-05       Impact factor: 3.442

7.  Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet       Date:  2018-11-08       Impact factor: 79.321

8.  Quality of Life in Depressed Patients in UK Primary Care: The FINDER Study.

Authors:  Alan Lenox-Smith; Mark T B Macdonald; Catherine Reed; Andre Tylee; Robert Peveler; Deborah Quail; Hiram J Wildgust
Journal:  Neurol Ther       Date:  2013-03-13

9.  Improvement in quality of life in depressed patients following verum acupuncture or electroacupuncture plus paroxetine: A randomized controlled study of 157 cases.

Authors:  Shenghui Ma; Shanshan Qu; Yong Huang; Junqi Chen; Renyong Lin; Chongqi Wang; Ganlong Li; Canghuan Zhao; Shenchang Guo; Zhangjin Zhang
Journal:  Neural Regen Res       Date:  2012-09-25       Impact factor: 5.135

10.  Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting.

Authors:  Jihyung Hong; Diego Novick; William Montgomery; Maria Victoria Moneta; Héctor Dueñas; Xiaomei Peng; Josep Maria Haro
Journal:  Patient Prefer Adherence       Date:  2015-10-16       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.